Skip to main content

Advertisement

Log in

Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients

  • Letter to the Editor
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bukowski RM: Sunitinib in advanced renal cell carcinoma: new treatment option. Curr Oncol Rep 2007, 9:87–88.

    Article  Google Scholar 

  2. Motzer RJ, Rini BI, Bukowski EM: Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006, 295:2516–2524.

    Article  PubMed  CAS  Google Scholar 

  3. Raspollini MR, Amunni G, Villanucci A, et al.: Cyclo-oxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma. Am J Obstet Gynecol 2006, 194:1203.

    Article  PubMed  CAS  Google Scholar 

  4. Donskov F, von der Maase II: Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol 2006, 24:1997–2005.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Rosaria Raspollini MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raspollini, M.R. Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients. Curr Oncol Rep 9, 331 (2007). https://doi.org/10.1007/s11912-007-0042-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-007-0042-z

Keywords

Navigation